MRAs treatment for Heart Failure

MRAs or Mineralocorticoid receptor antagonist drugs have been used in heart failure patients for over 20 years and again are a key tenet of heart failure medication. There's strong evidence to show that they really help improve the overall mortality and morbidity in patients with heart failure. It tends to be used in patients who have an ejection fraction under 40 percent and who have symptoms of heart failure. They can sometimes lower the blood pressure so if you feel particularly light-headed after starting the drug then discuss that with your doctor. Otherwise, for the vast majority of patients, they really do help in terms of survival and symptoms from heart failure. There are two different types available, both spironolactone and a pleironone and I think there are new drugs as well that'll be coming out soon.